Page last updated: 2024-10-28

halothane and Pulmonary Disease, Chronic Obstructive

halothane has been researched along with Pulmonary Disease, Chronic Obstructive in 2 studies

Pulmonary Disease, Chronic Obstructive: A disease of chronic diffuse irreversible airflow obstruction. Subcategories of COPD include CHRONIC BRONCHITIS and PULMONARY EMPHYSEMA.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Nickel, EA1
Benken, I1
Bartels, U1
Voelckel, WG1
Quintel, M1
Sirtl, C1
Laubenthal, H1
Meiser, A1

Other Studies

2 other studies available for halothane and Pulmonary Disease, Chronic Obstructive

ArticleYear
[AnaConDa as last resort treatment. Case report of a chronic obstructive pulmonary disease].
    Der Anaesthesist, 2007, Volume: 56, Issue:6

    Topics: Aged; Anesthesia, Closed-Circuit; Anesthesia, Inhalation; Anesthetics, Inhalation; Carbon Dioxide; C

2007
[AnaConDa].
    Der Anaesthesist, 2007, Volume: 56, Issue:12

    Topics: Aged; Anesthesia, General; Anesthesia, Inhalation; Anesthetics, Inhalation; Critical Care; Halothane

2007